Cargando…

MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity

Myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD) is an inflammatory demyelinating CNS condition characterized by the presence of MOG autoantibodies. We sought to investigate whether human MOG autoantibodies are capable of mediating damage to MOG-expressing cells through...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yandamuri, Soumya S., Filipek, Beata, Obaid, Abeer H., Lele, Nikhil, Thurman, Joshua M., Makhani, Naila, Nowak, Richard J., Guo, Yong, Lucchinetti, Claudia F., Flanagan, Eoin P., Longbrake, Erin E., O’Connor, Kevin C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393237/ https://www.ncbi.nlm.nih.gov/pubmed/37097758 http://dx.doi.org/10.1172/jci.insight.165373

Ejemplares similares

Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis
por: Obaid, Abeer H., et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
por: Sechi, Elia, et al.
Publicado: (2022)

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
por: Fadda, Giulia, et al.
Publicado: (2022)

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD
por: Lin, Liuyu, et al.
Publicado: (2022)

Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
por: Fichtner, Miriam L., et al.
Publicado: (2022)

Clinical and neuroimaging findings in MOGAD–MRI and OCT
por: Bartels, Frederik, et al.
Publicado: (2021)

Attack phenotypes and disease course in pediatric MOGAD
por: Santoro, Jonathan D., et al.
Publicado: (2023)

Editorial: MOGAD, current knowledge and future trends
por: Siritho, Sasitorn, et al.
Publicado: (2023)

NMOSD and MOGAD Dual Positivity: An Extremely Rare Phenomenon
por: Agarwal, Ayush, et al.
Publicado: (2022)

Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis
por: Vandendriessche, Sofie, et al.
Publicado: (2021)

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
por: Höftberger, Romana, et al.
Publicado: (2020)

Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2
por: Graf, Jonas, et al.
Publicado: (2020)

Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1
por: Graf, Jonas, et al.
Publicado: (2020)

Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
por: Derdelinckx, Judith, et al.
Publicado: (2021)

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course
por: Rechtman, Ariel, et al.
Publicado: (2022)

Demystifying MOGAD and Double Seronegative NMOSD Further With IL-6 Blockade
por: Yong, Kok Pin, et al.
Publicado: (2021)

The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
por: Yao, Yajun, et al.
Publicado: (2022)

Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China
por: Fan, Xiao, et al.
Publicado: (2022)

MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature
por: Du, Yangsa, et al.
Publicado: (2022)

The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD
por: Berhanu, David, et al.
Publicado: (2023)

Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis
por: Yandamuri, Soumya S., et al.
Publicado: (2016)

Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors
Publicado: (1987)

The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes
por: Gavin, Caroline, et al.
Publicado: (2019)

A Case of MOGAD Complicated With Cerebral Vasculitis: Case Report and Literature Review
por: Cao, Yimin, et al.
Publicado: (2023)

Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD
por: Kim, Sohyeon, et al.
Publicado: (2023)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
por: Al-Ani, Abdullah, et al.
Publicado: (2023)

Factor H Autoantibodies and Complement-Mediated Diseases
por: Zhang, Yuzhou, et al.
Publicado: (2020)

Remission of severe myasthenia gravis after autologous stem cell transplantation
por: Schlatter, Monica I., et al.
Publicado: (2023)

Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis
por: Bushey, Ryan T., et al.
Publicado: (2021)

THE ENHANCEMENT OF BACTERIAL PHAGOCYTOSIS BY SERUM : THE ROLE OF COMPLEMENT COMPONENTS AND TWO COFACTORS
por: Johnston, Richard B., et al.
Publicado: (1969)

The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
por: Sen, Sedat, et al.
Publicado: (2022)

High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challenge
por: Azar, Chadi, et al.
Publicado: (2023)

Autoantibodies against complement factor B in rheumatoid arthritis
por: Matola, Alexandra T., et al.
Publicado: (2023)

Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1
por: Boero, Elena, et al.
Publicado: (2023)

Complement Therapeutics in Autoimmune Disease
por: Thurman, Joshua M., et al.
Publicado: (2019)

The Role of Complement in Organ Transplantation
por: Grafals, Monica, et al.
Publicado: (2019)

The Multiple Sclerosis Prodrome: Evidence to Action
por: Tremlett, Helen, et al.
Publicado: (2022)

Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction
por: Milde, Ronny, et al.
Publicado: (2015)

Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System
por: Borucki, Davis M., et al.
Publicado: (2020)

Complement Receptor-Mediated Phagocytosis Induces Proinflammatory Cytokine Production in Murine Macrophages
por: Acharya, Durga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vhvjatjm164sdb6i951l4hk5ft